Literature DB >> 10939935

Screening hCHK2 for mutations.

N Sodha1, R Williams, J Mangion, S L Bullock, M R Yuille, R A Eeles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10939935     DOI： 10.1126/science.289.5478.359a

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  18 in total

Review 1.  The contribution of inherited factors to the clinicopathological features and behavior of breast cancer.

Authors:  W D Foulkes; J Rosenblatt; P O Chappuis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

2.  CHEK2 is a multiorgan cancer susceptibility gene.

Authors:  C Cybulski; B Górski; T Huzarski; B Masojć; M Mierzejewski; T Debniak; U Teodorczyk; T Byrski; J Gronwald; J Matyjasik; E Zlowocka; M Lenner; E Grabowska; K Nej; J Castaneda; K Medrek; A Szymańska; J Szymańska; G Kurzawski; J Suchy; O Oszurek; A Witek; S A Narod; J Lubiński
Journal:  Am J Hum Genet       Date:  2004-10-18       Impact factor: 11.025

3.  Li-fraumeni syndrome.

Authors:  David Malkin
Journal:  Genes Cancer       Date:  2011-04

4.  Chk2 activation and phosphorylation-dependent oligomerization.

Authors:  Xingzhi Xu; Lyuben M Tsvetkov; David F Stern
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

5.  Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability.

Authors:  Aglaya G Iyevleva; Svetlana N Aleksakhina; Anna P Sokolenko; Sofia V Baskina; Aigul R Venina; Elena I Anisimova; Ilya V Bizin; Alexandr O Ivantsov; Yana V Belysheva; Alexandra P Chernyakova; Alexandr V Togo; Evgeny N Imyanitov
Journal:  Breast Cancer Res Treat       Date:  2022-01-12       Impact factor: 4.872

6.  Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer.

Authors:  Marc D Tischkowitz; Ahmet Yilmaz; Long Q Chen; Danielle M Karyadi; David Novak; Tomas Kirchhoff; Nancy Hamel; Sean V Tavtigian; Suzanne Kolb; Tarek A Bismar; Raquel Aloyz; Peter S Nelson; Lee Hood; Steven A Narod; Kirsten A White; Elaine A Ostrander; William B Isaacs; Kenneth Offit; Kathleen A Cooney; Janet L Stanford; William D Foulkes
Journal:  Cancer Lett       Date:  2008-06-20       Impact factor: 8.679

7.  Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk.

Authors:  Kristjana Einarsdóttir; Keith Humphreys; Carine Bonnard; Juni Palmgren; Mark M Iles; Arvid Sjölander; Yuqing Li; Kee Seng Chia; Edison T Liu; Per Hall; Jianjun Liu; Sara Wedrén
Journal:  PLoS Med       Date:  2006-05-09       Impact factor: 11.069

8.  Evolutionary analysis of the highly dynamic CHEK2 duplicon in anthropoids.

Authors:  Claudia Münch; Stefan Kirsch; António M G Fernandes; Werner Schempp
Journal:  BMC Evol Biol       Date:  2008-10-02       Impact factor: 3.260

9.  Mutation analysis of the CHK2 gene in breast carcinoma and other cancers.

Authors:  Sigurdur Ingvarsson; Bjarnveig I Sigbjornsdottir; Chen Huiping; Sigridur H Hafsteinsdottir; Gisli Ragnarsson; Rosa B Barkardottir; Adalgeir Arason; Valgardur Egilsson; Jon T H Bergthorsson
Journal:  Breast Cancer Res       Date:  2002-03-20       Impact factor: 6.466

10.  CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer.

Authors:  Peilin Zhang; Jie Wang; Weiyi Gao; Bao-Zhu Yuan; John Rogers; Eddie Reed
Journal:  Mol Cancer       Date:  2004-05-04       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.